The Intestinal Microbiota and Cellular Therapy: Implications for Impact and Mechanisms

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2024 Aug 14

PMID 39141827

Authors

Jiayi Xie

Melody Smith

Affiliations

Soon will be listed here.

Abstract

The microbiota, comprising bacteria, fungi, and viruses residing within our bodies, functions as a key modulator in host health and states, including immune responses. Studies have linked microbiota and microbiota-derived metabolites to immune cell functions. In this review, we probe the complex relationship between the human microbiota and clinical outcomes of cellular therapies that leverage immune cells to fight various cancers. With a particular emphasis on hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy, we explore the potential mechanisms underpinning this interaction. We also highlight the interventional applications of the microbiota in cellular therapy while outlining future research directions in the field.

Citing Articles

Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells.

Staudt S, Nikolka F, Perl M, Franz J, Leblay N, Leblay N bioRxiv. 2024; .

PMID: 39314273 PMC: 11418944. DOI: 10.1101/2024.08.19.608538.

References

Haak B, Littmann E, Chaubard J, Pickard A, Fontana E, Adhi F . Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018; 131(26):2978-2986. PMC: 6024637. DOI: 10.1182/blood-2018-01-828996. View

Henig I, Zuckerman T . Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J. 2014; 5(4):e0028. PMC: 4222417. DOI: 10.5041/RMMJ.10162. View

Mager L, Burkhard R, Pett N, Cooke N, Brown K, Ramay H . Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020; 369(6510):1481-1489. DOI: 10.1126/science.abc3421. View

Fischer J, Bscheider M, Eisenkolb G, Lin C, Wintges A, Otten V . RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury. Sci Transl Med. 2017; 9(386). PMC: 5604790. DOI: 10.1126/scitranslmed.aag2513. View

Routy B, Letendre C, Enot D, Chenard-Poirier M, Mehraj V, Seguin N . The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. Oncoimmunology. 2017; 6(1):e1258506. PMC: 5283637. DOI: 10.1080/2162402X.2016.1258506. View

Kuczma M, Ding Z, Li T, Habtetsion T, Chen T, Hao Z . The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. Oncotarget. 2018; 8(67):111931-111942. PMC: 5762370. DOI: 10.18632/oncotarget.22953. View

Elgarten C, Li Y, Getz K, Hemmer M, Huang Y, Hall M . Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease. Transplant Cell Ther. 2021; 27(2):177.e1-177.e8. PMC: 7946150. DOI: 10.1016/j.jtct.2020.10.012. View

Seike K, Kiledal A, Fujiwara H, Henig I, Burgos da Silva M, van den Brink M . Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation. Immunity. 2023; 56(2):353-368.e6. PMC: 11098523. DOI: 10.1016/j.immuni.2023.01.007. View

Schluter J, Peled J, Taylor B, Markey K, Smith M, Taur Y . The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020; 588(7837):303-307. PMC: 7725892. DOI: 10.1038/s41586-020-2971-8. View

10.

Zeiser R, Blazar B . Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017; 377(22):2167-2179. PMC: 6034180. DOI: 10.1056/NEJMra1609337. View

11.

Dougan M, Luoma A, Dougan S, Wucherpfennig K . Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021; 184(6):1575-1588. PMC: 7979511. DOI: 10.1016/j.cell.2021.02.011. View

12.

Rao J, Xiao L, Wang J . Polyamines in Gut Epithelial Renewal and Barrier Function. Physiology (Bethesda). 2020; 35(5):328-337. PMC: 7642847. DOI: 10.1152/physiol.00011.2020. View

13.

Zhai B, Ola M, Rolling T, Tosini N, Joshowitz S, Littmann E . High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat Med. 2020; 26(1):59-64. PMC: 7005909. DOI: 10.1038/s41591-019-0709-7. View

14.

Rosenberg S, Packard B, Aebersold P, Solomon D, Topalian S, TOY S . Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med. 1988; 319(25):1676-80. DOI: 10.1056/NEJM198812223192527. View

15.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak J . in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol Res. 2018; 6(11):1327-1336. PMC: 6215508. DOI: 10.1158/2326-6066.CIR-18-0174. View

16.

Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S . Regulation of the effector function of CD8 T cells by gut microbiota-derived metabolite butyrate. Sci Rep. 2018; 8(1):14430. PMC: 6158259. DOI: 10.1038/s41598-018-32860-x. View

17.

Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z . CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nat Commun. 2022; 13(1):5313. PMC: 9461447. DOI: 10.1038/s41467-022-32960-3. View

18.

Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl G, Dawin E . Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell. 2020; 180(6):1067-1080.e16. DOI: 10.1016/j.cell.2020.02.035. View

19.

Neemann K, Eichele D, Smith P, Bociek R, Akhtari M, Freifeld A . Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012; 14(6):E161-5. DOI: 10.1111/tid.12017. View

20.

Henry C, Ornelles D, Mitchell L, Brzoza-Lewis K, Hiltbold E . IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol. 2008; 181(12):8576-84. PMC: 2716729. DOI: 10.4049/jimmunol.181.12.8576. View